Genetic profiles of fluoroquinolone-resistant Escherichia coli isolates obtained from patients with cystitis: Phylogeny, virulence factors, PAIusp subtypes, and mutation patterns

Journal of Clinical Microbiology

Volumn 47, Issue 3, 2009, Pages 791-795

  Takahashi, Akira ^a   Muratani, Tetsuro ^b   Yasuda, Mitsuru ^b   Takahashi, Satoshi ^b   Monden, Koichi ^b   Ishikawa, Kiyohito ^b   Kiyota, Hiroshi ^b   Arakawa, Soichi ^b   Matsumoto, Tetsuro ^b   Shima, Hiroki ^b   Kurazono, Hisao ^c   Yamamoto, Shingo ^b,d  

^a KYOTO UNIVERSITY   (Japan)

^b Japanese Research Group for UTI (JRGU)   (Japan)

^c OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

^d HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING) A; DNA TOPOISOMERASE (ATP HYDROLYSING) B; PROTEIN PARC; PROTEIN PARE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VIRULENCE FACTOR;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CONTROLLED STUDY; CYSTITIS; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; CYSTITIS; DNA GYRASE; DRUG RESISTANCE, BACTERIAL; EPIDEMIOLOGY, MOLECULAR; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FLUOROQUINOLONES; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION, MISSENSE; PHYLOGENY; VIRULENCE FACTORS;

ESCHERICHIA COLI;

EID: 62749160869     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01740-08     Document Type: Article

References (20)

1. Bachoual, R., J. Tankovic, and C. J. Soussy. 1998. Analysis of the mutations involved in fluoroquinolone resistance of in vivo and in vitro mutants of Escherichia coli. Microb. Drug Resist. 4:271-276.
2. Breines, D. M., S. Ouabdesselam, E. Y. Ng, J. Tancovic, S. Shah, C. J. Soussy, and D. C. Hooper. 1997. Quinolone resistance locus nfxD of Escherichia coli is a mutant allele of the pare gene encoding a subunit of topoisomerase IV. Antimicrob. Agents Chemother. 41:175-179.
3. Clermont, O., S. Bonacorsi, and E. Bingen. 2000. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 66:4555-4558.
4. Clinical and Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 7th ed. Approved standard, document M7-A7. Clinical and Laboratory Standards Institute, Wayne, PA.
5. Drews, S. J., S. M. Poutanen, T. Mazzulli, A. J. McGeer, A. Sarabia, S. Pong-Porter, Y. Rzayev, B. Willey, K. Green, and D. E. Low. 2005. Decreased prevalence of virulence factors among ciprofloxacin-resistant uropathogenic Escherichia coli isolates. J. Clin. Microbiol. 43:4218-4220.
6. Everett, M. J., Y. F. Jin, V. Ricci, and L. J. Piddock. 1996. Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals. Antimicrob. Agents Chemother. 40:2380-2386.
7. Gobernado, M., L. Valdes, J. I. Alos, C. Garcia-Rey, R. Dal-Re, J. Garcia-de-Lomas, and the Spanish Surveillance Group for Urinary Pathogens. 2007. Antimicrobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1-year period in Spain. Rev. Esp. Quimioter. 20:68-76.
8. Houdouin, V., S. Bonacorsi, P. Bidet, M. Bingen-Bidois, D. Barraud, and E. Bingen. 2006. Phylogenetic background and carriage of pathogenicity island-like domains in relation to antibiotic resistance profiles among Escherichia coli urosepsis isolates. J. Antimicrob. Chemother. 58:748-751.
9. Johnson, J. R., M. A. Kuskowski, K. Owens, A. Gajewski, and P. L. Winokur. 2003. Phylogenetic origin and virulence genotype in relation to resistance to fluoroquinolones and/or extended-spectrum cephalosporins and cephamycins among Escherichia coli isolates from animals and humans. J. Infect. Dis. 188:759-768.
10. Kahlmeter, G., and P. Menday. 2003. Cross-resistance and associated resistance in 2478 Escherichia coli isolates from the Pan-European ECO-SENS Project surveying the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections. J. Antimicrob. Chemother. 52:128-131.
11. Kanamaru, S., H. Kurazono, M. Nakano, A. Terai, O. Ogawa, and S. Yamamoto. 2006. Subtyping of uropathogenic Escherichia coli according to the pathogenicity island encoding uropathogenic-specific protein: comparison with phylogenetic groups. Int. J. Urol. 13:754-760.
12. Kumamoto, Y., T. Tsukamoto, M. Matsukawa, Y. Kunishima, T. Hirose, S. Shigeta, O. Yamaguchi, K. Ishibashi, T. Suzutani, H. Yoshida, Y. Imafuku, M. Murai, K. Watanabe, Y. Kobayashi, H. Uchida, S. Matsuda, S. Sato, M. Fujime, K. Fujita, J. Igari, T. Oguri, K. Yamaguchi, N. Furuya, T. Deguchi, S. Ishihara, H. Ooe, T. Oka, M. Kitamura, Y. Fukuhara, S. Kamidono, S. Arakawa, H. Kumon, K. Monden, T. Matsumoto, T. Muratani, S. Naito, T. Egashira, T. Konishi, S. Kohno, Y. Hirakata, A. Kondo, J. Matsuda, and M. Nakano. 2006. Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). Jpn. J. Antibiot. 59:177-315. (In Japanese.)
13. Lindgren, P. K., A. Karlsson, and D. Hughes. 2003. Mutation rate and evolution of fluoroquinolone resistance in Escherichia coli isolates from patients with urinary tract infections. Antimicrob. Agents Chemother. 47:3222-3232.
14. Moreno, E., G. Prats, M. Sabate, T. Perez, J. R. Johnson, and A. Andreu. 2006. Quinolone, fluoroquinolone and trimethoprim/sulfamethoxazole resistance in relation to virulence determinants and phylogenetic background among uropathogenic Escherichia coli. J. Antimicrob. Chemother. 57:204-211.
15. Piatti, G., A. Mannini, M. Balistreri, and A. M. Schito. 2008. Virulence factors in urinary Escherichia coli strains: phylogenetic background and quinolone and fluoroquinolone resistance. J. Clin. Microb. 46:480-487.
16. Sorlozano, A., J. Gutierrez, A. Jimenez, J. D. Luna, and J. L. Martinez. 2007. Contribution of a new mutation in parE to quinolone resistance in extended-spectrum-beta-lactamase-producing Escherichia coli isolates. J. Clin. Microbiol. 45:2740-2742.
17. Takahashi, A., S. Kanamaru, H. Kurazono, Y. Kunishima, T. Tsukamoto, O. Ogawa, and S. Yamamoto. 2006. Escherichia coli isolates associated with uncomplicated and complicated cystitis and asymptomatic bacteriuria possess similar phylogenies, virulence genes, and O-serogroup profiles. J. Clin. Microbiol. 44:4589-4592.
18. Vila, J., J. Ruiz, P. Goni, and M. T. de Anta. 1996. Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coli. Antimicrob. Agents Chemother. 40:491-493.
19. Vila, J., K. Simon, J. Ruiz, J. P. Horcajada, M. Velasco, M. Barranco, A. Moreno, and J. Mensa. 2002. Are quinolone-resistant uropathogenic Escherichia coli less virulent? J. Infect. Dis. 186:1039-1042.
20. Zhanel, G. G., T. L. Hisanaga, N. M. Laing, M. R. DeCorby, K. A. Nichol, B. Weshnoweski, J. Johnson, A. Noreddin, D. E. Low, and J. A. Karlowski for the NAUTICA Group and D. J. Hoban. 2006. Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). Int. J. Antimicrob. Agents 27:468-475.